This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Hoffmann-La Roche Inc., ETH Zurich, Unversität Zürich. Active years: 2015-2019.
Company Filing History:
2 out of 5,020 
1 out of 554 
1 out of 276 
Years Active: 2015-2019
Title: Juergen Fingerle: Innovator in Radiolabeled Compounds
Introduction
Juergen Fingerle is a notable inventor based in Kandern, Germany. He has made significant contributions to the field of radiolabeled compounds, holding two patents that showcase his innovative spirit and expertise.
Latest Patents
Fingerle's latest patents include a radiolabeled cannabinoid receptor 2 ligand. This invention relates to a compound of formula (I), which can be utilized as a radiolabeled ligand. His second patent involves tetranectin-apolipoprotein A-I, lipid particles containing it, and its various uses. This lipid particle comprises an apolipoprotein, a phosphatidylcholine, and a lipid, such as a phospholipid, fatty acid, or steroid lipid. The patent details various embodiments of the lipid particle, emphasizing the specific characteristics of the apolipoprotein and phosphatidylcholine involved.
Career Highlights
Throughout his career, Fingerle has worked with prominent companies, including Hoffmann-La Roche Inc. His experience in the pharmaceutical industry has allowed him to develop innovative solutions that contribute to advancements in medical science.
Collaborations
Fingerle has collaborated with notable colleagues, including Martin Bader and Monika Baehner. These partnerships have likely enriched his work and contributed to the success of his inventions.
Conclusion
Juergen Fingerle's contributions to the field of radiolabeled compounds highlight his innovative capabilities and dedication to advancing medical research. His patents reflect a commitment to developing new solutions that can have a significant impact on healthcare.